PharmaResearch Co., Ltd. (KOSDAQ:214450)
South Korea · Delayed Price · Currency is KRW 413,500
+22,500 (5.75%)
Aug 20, 2026, 3:30 PM KST
PharmaResearch Market Cap
PharmaResearch has a market cap or net worth of 4.3 trillion as of August 20, 2026. Its market cap has decreased by -38.74% in one year.
Market Cap
4.30T
Enterprise Value
3.92T
Revenue
565.48B
Ranking
n/a
PE Ratio
26.02
Stock Price
413,500.00
ChartMarket Cap Chart
Since July 24, 2015, PharmaResearch's market cap has increased from 1.01T to 4.30T, an increase of 325.67%. That is a compound annual growth rate of 13.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 4.30T | 2.61% |
| Dec 30, 2025 | 4.19T | 53.52% |
| Dec 30, 2024 | 2.73T | 144.17% |
| Dec 28, 2023 | 1.12T | 60.18% |
| Dec 29, 2022 | 697.32B | -14.76% |
| Dec 30, 2021 | 818.02B | 48.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.78T |
| Celltrion | 44.51T |
| ALTEOGEN | 23.64T |
| Samsung Epis Holdings | 9.03T |
| HLB Co., Ltd. | 5.30T |
| Hanmi Pharm. | 5.06T |
| ABL Bio | 4.62T |
| Peptron | 4.33T |